Mirror Therapy for Stroke Rehabilitation
(MiraPi Trial)

Recruiting in Palo Alto (17 mi)

Overseen byNecolle Morgado-Vega

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Yale University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a randomized controlled trial which will compare conventional mirror therapy with mirror therapy using the Miraπ device which physically moves a patient's affected limb. This study will use two parallel groups: (1) receiving conventional mirror therapy as a part of the standard of care as conducted by the participant's clinical care team and (2) receiving mirror therapy with the Miraπ device as conducted by study personnel with the oversight of the participant's clinical care team.

Research Team

Necolle Morgado-Vega

Principal Investigator

Yale University

Eligibility Criteria

This trial is for individuals who have experienced a stroke and are dealing with pain or weakness as a result. Participants should be under the care of a clinical team and willing to undergo mirror therapy, either conventional or using the Miraπ device.

Inclusion Criteria

I am approved for inpatient rehabilitation by the medical director.

My doctor has approved mirror therapy for my rehabilitation.

I have paralysis or trouble moving only one of my hands.

See 2 more

Exclusion Criteria

I am not medically cleared for standard inpatient rehab therapies.

I am under 18 years old.

Vulnerable populations

See 2 more

Treatment Details

Interventions

Miraπ (Procedure)
Mirror Therapy (Behavioral Intervention)

Trial OverviewThe study compares two types of mirror therapy: traditional mirror therapy provided by participants' own healthcare teams versus innovative Miraπ-assisted therapy overseen by study personnel in collaboration with those teams.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Miraπ GroupExperimental Treatment1 Intervention

Participants in this group will train with the Miraπ device, performing it on the affected arm for 15 minutes daily, 3 days per week until their discharge from clinic (approximately 2-3 weeks).

Group II: Conventional Therapy GroupActive Control1 Intervention

Participants in this group with train using Mirror Therapy (MT), the current standard of care, performing it on the affected arm for 15 minutes daily, 3 days per week until their discharge from clinic (approximately 2-3 weeks).